Can dexamethasone (Decadron) be prescribed for a sore throat caused by infectious mononucleosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dexamethasone for Infectious Mononucleosis with Sore Throat

Dexamethasone should NOT be routinely prescribed for sore throat in patients with infectious mononucleosis, but can be considered in severe cases with marked pharyngeal symptoms (3-4 Centor criteria) or impending airway obstruction.

Clinical Decision Framework

The evidence shows limited and inconsistent benefit from corticosteroids in infectious mononucleosis:

When NOT to Use Dexamethasone (Most Cases)

  • Routine symptom control is NOT indicated 1, 2
  • A Cochrane review found insufficient evidence for efficacy, with only 2 of 10 health assessments showing any benefit 1
  • One pediatric trial showed pain relief only at 12 hours, with no sustained benefit at 24,48, or 72 hours 3
  • Current evidence points to "small and inconsistent benefits" that do not justify routine use 2

When to Consider Dexamethasone (Severe Cases Only)

Reserve corticosteroids for:

  • Impending airway obstruction 2, 4
  • Severe pharyngeal edema with respiratory compromise 4
  • Marked severe presentation (3-4 Centor criteria) 5

The general sore throat guideline states that corticosteroids with antibiotics can be considered in adults with severe presentations (3-4 Centor criteria), but this was not specific to mononucleosis 5.

Safety Considerations

Corticosteroids appear generally safe when used with antibiotics 6:

  • A 2025 retrospective study of 396 patients found similar rates of severe complications (peritonsillar abscess, bacteremia, splenic rupture) whether or not corticosteroids were used
  • However, 89.7% of corticosteroid-treated patients also received antibiotics, suggesting safety may depend on concurrent antibiotic coverage
  • Isolated adverse events have been reported, including respiratory distress and acute diabetes onset 1

Recommended Approach

For typical infectious mononucleosis with sore throat:

  1. First-line treatment: Ibuprofen or acetaminophen for pain relief 5
  2. Supportive care: Adequate hydration, rest as tolerated, avoid contact sports for 8 weeks 4, 7
  3. Avoid routine corticosteroids 2

For severe presentations only:

  • If airway compromise or severe pharyngeal edema is present, consider dexamethasone 0.3 mg/kg (maximum 15 mg) orally 3
  • Monitor closely for complications
  • Consider concurrent antibiotic coverage if bacterial superinfection is suspected 6

Critical Pitfall

Do not prescribe corticosteroids simply because the patient has a positive monospot test and sore throat. The evidence does not support routine use, and any benefit is short-lived and clinically insignificant in most cases 3, 1. The risk-benefit ratio favors conservative management with NSAIDs for typical presentations.

References

Research

Steroids for symptom control in infectious mononucleosis.

The Cochrane database of systematic reviews, 2015

Research

Corticosteroids for infectious mononucleosis.

Canadian family physician Medecin de famille canadien, 2023

Research

Epstein-Barr virus infectious mononucleosis.

American family physician, 2004

Guideline

guideline for the management of acute sore throat.

Clinical Microbiology and Infection, 2012

Research

Infectious Mononucleosis: An Updated Review.

Current pediatric reviews, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.